News Releases
View all Historical Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 25, 2016Awarded $3.2M to Conduct Preclincial Efficacy and Toxicology Studies
Princeton, NJ – May 25, 2016 – Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare...
-
May 12, 2016
Princeton, NJ – May 12, 2016 – Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare...
-
May 5, 2016Awarded $4.3M to Support Manufacturing Activities
Princeton, NJ – May 5, 2016 – Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare...
-
Apr 14, 2016Patents provide broad protection, including composition of matter claims
Princeton, NJ – April 14, 2016 – Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat...
-
Mar 29, 2016Preclinical Results Supported by Recent Positive Phase 2 Clinical Trial
Princeton, NJ – March 29, 2016 – Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat...
-
Mar 24, 2016Highlighted by Revenues of $8.8 Million
Princeton, NJ – March 24, 2016 – Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat...
-
Mar 17, 2016Awarded $660,000 to accelerate regulatory interactions with FDA
Princeton, NJ – March 17, 2016 – Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat...
-
Feb 2, 2016
Princeton, NJ – February 2, 2016 – Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat...
-
Jan 26, 2016
Princeton, NJ – January 26, 2016 – Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat...